Sign In
Buy VCEL
$34.74
+0.290 (+0.84%)
At Close: Jun 03, 2026
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
08:00am, Monday, 01'st Apr 2024
The top five biotech stocks today have several commonalities. Among them are strong ratings.
Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript
11:39am, Thursday, 29'th Feb 2024
Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript
Vericel Corporation (VCEL) Q4 Earnings Beat Estimates
10:06am, Thursday, 29'th Feb 2024
Vericel Corporation (VCEL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.12 per share a year ago.
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
07:55am, Thursday, 29'th Feb 2024
Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0 Million, with Adjusted EBITDA Growth of 50% Fourth
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
08:30am, Tuesday, 27'th Feb 2024
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Co
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
11:29am, Monday, 26'th Feb 2024
Pharma stocks and massive potential are synonymous. With horrible diseases like cancer, diabetes, and heart disease still a mile away from developing a cure, drugs that address these conditions comman
Are You Looking for a Top Momentum Pick? Why Vericel Corporation (VCEL) is a Great Choice
01:01pm, Thursday, 22'nd Feb 2024
Does Vericel Corporation (VCEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Vericel Corporation (VCEL) to Report Q4 Results: Wall Street Expects Earnings Growth
11:06am, Thursday, 15'th Feb 2024
Vericel Corporation (VCEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vericel Corporation (VCEL) is on the Move, Here's Why the Trend Could be Sustainable
09:51am, Thursday, 15'th Feb 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Vericel Corporation (VCEL) could be a great choice. It is one of the several stocks that passed through our "Re
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
08:30am, Thursday, 15'th Feb 2024
CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will
5 medical stocks growing earnings by triple digits
10:46am, Tuesday, 06'th Feb 2024
While most of the market focuses on hyper-growth technology stocks rewarded by Wall Street as long as they mention the word "artificial intelligence" in their earnings calls, the reality is that the
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
08:30am, Monday, 05'th Feb 2024
CAMBRIDGE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Co
Recent Price Trend in Vericel Corporation (VCEL) is Your Friend, Here's Why
09:50am, Tuesday, 30'th Jan 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Vericel Corporation (VCEL) could be a great choice. It is one of the several stocks that passed through our "Re
Vericel Corporation (VCEL) Moves 7.0% Higher: Will This Strength Last?
10:31am, Tuesday, 09'th Jan 2024
Vericel Corporation (VCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
07:55am, Tuesday, 09'th Jan 2024
Full-Year Total Revenue Expected to be Approximately $197.5 Million, Representing 20% Growth, with Fourth Quarter Revenue Growth of 23% to $65 Million
